...
首页> 外文期刊>American Journal of Physiology >Contribution of adenosine A2A and A2B receptors and heme oxygenase to AMPA-induced dilation of pial arterioles in rats.
【24h】

Contribution of adenosine A2A and A2B receptors and heme oxygenase to AMPA-induced dilation of pial arterioles in rats.

机译:腺苷A2A和A2B受体和血红素加氧酶对AMPA诱导的大鼠小动脉扩张的贡献。

获取原文
获取原文并翻译 | 示例

摘要

Nitric oxide (NO) has been implicated in mediation of cerebral vasodilation during neuronal activation and, specifically, in pharmacological activation of N-methyl-d-aspartate (NMDA) and kainate receptors. Possible mediators of cerebral vasodilation to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) have not been well studied in mature brain, although heme oxygenase (HO) activity has been implicated in newborn pigs. In anesthetized rats, 5 min of topical superfusion of 30 and 100 microM AMPA on the cortical surface through a closed cranial window resulted in increases in pial arteriolar diameter. The dilatory response to AMPA was not inhibited by superfusion of an NO synthase inhibitor, a cyclooxygenase-2 inhibitor, or a cytochrome P-450 epoxygenase inhibitor, all of which have been shown to inhibit the cortical blood flow response to sensory activation. However, the 48 +/- 13% dilation to 100 microM AMPA was attenuated 56-71% by superfusion of the adenosine A(2A) receptor antagonist ZM-241385, the A(2B) receptor antagonist alloxazine, and the HO inhibitor chromium mesoporphyrin. Combination of the latter three inhibitors did not attenuate the dilator response more than the individual inhibitors, whereas an AMPA receptor antagonist fully blocked the vasodilation to AMPA. These results indicate that cortical pial arteriolar dilation to AMPA does not require activation of NO synthase, cyclooxygenase-2, or cytochrome P-450 epoxygenase but does depend on activation of adenosine A(2A) and A(2B) receptors. In addition, CO derived from HO appears to play a role in the vascular response to AMPA receptor activation in mature brain by a mechanism that is not additive with that of adenosine receptor activation.
机译:一氧化氮(NO)与神经元激活过程中脑血管舒张有关,特别是N-甲基-d-天门冬氨酸(NMDA)和海藻酸盐受体的药理活性。尽管新生血球中涉及血红素加氧酶(HO)的活性,但尚未在成熟的脑中很好地研究脑血管舒张为α-氨基-3-羟基-5-甲基异恶唑-4-丙酸(AMPA)的可能介质。在麻醉的大鼠中,通过封闭的颅窗在皮质表面局部灌注30和100 microM AMPA 5分钟,导致皮层小动脉直径增加。 NO合酶抑制剂,环氧合酶2抑制剂或细胞色素P-450环氧合酶抑制剂的融合并没有抑制对AMPA的扩张反应,所有这些均已显示出它们抑制了皮层血流对感觉激活的反应。但是,通过腺苷A(2A)受体拮抗剂ZM-241385,A(2B)受体拮抗剂alloxazine和HO抑制剂铬中卟啉的超融合,对100 microM AMPA的48 +/- 13%的扩张被减弱了56-71%。 。后三种抑制剂的组合并未比单独的抑制剂更能减轻扩张反应,而AMPA受体拮抗剂则完全阻断了对AMPA的血管舒张作用。这些结果表明,皮层小动脉向AMPA的扩张不需要激活NO合酶,环氧合酶2或细胞色素P-450环氧合酶,但确实取决于腺苷A(2A)和A(2B)受体的激活。另外,源自HO的CO似乎通过与腺苷受体激活的机制不相加的机制在成熟脑中对AMPA受体激活的血管反应中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号